Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Halberstadt, Adam L.·2015·Behavioural Brain Research
DOI 10.1016/j.bbr.2014.07.016

Cites (462)

Items 401–458 of 458

  1. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes
    Boris B. Gorzalka, Matthew N. Hill, Jane C. Sun · 2005 · European Journal of Pharmacology
  2. Effects of (±)-DOI on medial prefrontal cortical cells: a microiontophoretic study
    Charles R. Ashby, Emmeline Edwards, Kelly Harkins, Rex Y. Wang · 1989 · Brain Research
  3. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline
    James B. Appel, Patrick M. Callahan · 1989 · European Journal of Pharmacology
  4. In vivo effects of activation and blockade of 5-HT2A/2C receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease
    Shuang Wang, Qiaojun Zhang, Jian Liu, Umar Ali, Zhong Heng Wu, Li Chen, Zhen Hua Gui, Yong Wang, Yan Ping Hui · 2009 · Experimental Neurology
  5. Distribution of 5-HT2A receptor immunoreactivity in the rat amygdaloid complex and colocalization with γ-aminobutyric acid
    Cristiano Bombardi · 2010 · Brain Research
  6. Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation
    Evelyn K. Lambe, George K. Aghajanian · 2007 · Neuroscience
  7. Embryonic development of the nervous system of the rhabdocoel flatwormMesostoma lingua (Abildgaard, 1789)
    Amelia Younossi‐Hartenstein, Ulrich Ehlers, Volker Hartenstein · 2000 · The Journal of Comparative Neurology
  8. Effectiveness.of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states
    G. Verde, P. G. Chiodini, Antonio Liuzzi, Renato Cesare Cozzi, Fabrizio Favales, LIDUINA BOTALLA, BARBARA SPELTA, DANIELA DALLA BONZANA, Ernst Rainer, REINHARD HOROWSKI · 1980 · Journal of Endocrinological Investigation
  9. N-Methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane
    Richard A. Glennon, Milt Titeler, Mark R. Seggel, Robert A. Lyon · 1987 · Journal of Medicinal Chemistry
  10. Influence of Lysergic Acid Diethylamide (LSD-25) on Subjective Time
    H. Aronson · 1959 · Archives of General Psychiatry
  11. LSD, 5-HT (serotonin), and the evolution of a behavioral assay
    James B. Appel, William B West, James Buggy · 2003 · Neuroscience & Biobehavioral Reviews
  12. Discriminative stimulus properties of the hallucinogenic agent DOM.
    Richard Young, Richard A. Glennon, J A Rosecrans · 1980 · PubMed
  13. Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats
    Roberto Ciccocioppo, Stefania Angeletti, Giancarlo Colombo, GianLuigi Gessa, Maurizio Massi · 1999 · European Journal of Pharmacology
  14. Lysergic Acid Diethylamide (LSD-25) Antagonists
    Harold A. Abramson · 1958 · A M A Archives of Neurology & Psychiatry
  15. Subjective Light Pattern Spectroscopy in the Encephalographic Frequency Range
    Max Knoll, J Kugler · 1959 · Nature
  16. Progression of Effects of Lysergic Acid Diethylamide [LSD]
    Santo Salvatore · 1956 · Archives of Neurology And Psychiatry
  17. Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure
    Patrick M. Callahan, James B. Appel · 1990 · Psychopharmacology
  18. Subjective Effects ofSalvia Divinorum: LSD- or Marijuana-like?
    Dawn N. Albertson, Laura E. Grubbs · 2009 · Journal of Psychoactive Drugs
  19. Failure to block responses of locus coeruleus neurons to somatosensory stimuli by destruction of two major afferent nuclei
    Kurt Rasmussen, George K. Aghajanian · 1989 · Synapse
  20. Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse
    C. Singleton, Charles Alexander Marsden · 1981 · Psychopharmacology
  21. Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors
    S. Body, Timothy H. C. Cheung, G. Bezzina, Karim Asgari, Kevin C.F. Fone, Jeffrey Colm Glennon, C. M. Bradshaw, E. Szabadi · 2006 · Psychopharmacology
  22. Assessment of tolerance to the hallucinogenic effects of DOM
    BURTON M. ANGRIST, John Rotrosen, Samuel Gershon · 1974 · Psychopharmacology
  23. Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide
    Adams, Lynne M., Geyer, Mark A. · 1985 · Pharmacology Biochemistry and Behavior
  24. A primate model for the study of hallucinogens
    R. Francis Schlemmer, John M. Davis · 1986 · Pharmacology Biochemistry and Behavior
  25. Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine
    Minoru Narita, Kazumi Yoshizawa, Mutsuko Nomura, Kazue Aoki, Tsutomu Suzuki · 2001 · European Journal of Pharmacology
  26. Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT2A/2C receptor stimulation in the rat
    Qiaojun Zhang, Shuang Wang, Jian Liu, Umar Ali, Zhen Hua Gui, Zhong Heng Wu, Yan Ping Hui, Yong Wang, Li Chen · 2009 · Brain Research
  27. Comparison of the effects of 2,5-dimethoxy-4-iodoamphetamine and D-amphetamine on the ability of rats to discriminate the durations and intensities of light stimuli
    C. L. Hampson, S. Body, Femke S. den Boon, Timothy H. C. Cheung, G. Bezzina, R. W. Langley, Kevin C.F. Fone, C. M. Bradshaw, E. Szabadi · 2010 · Behavioural Pharmacology
  28. N,N-Di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin
    Richard A. Glennon, Milt Titeler, Robert A. Lyon, R. M. Slusher · 1988 · Journal of Medicinal Chemistry
  29. Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice
    Nobuaki Egashira, Atsunori Shirakawa, Ryoko Okuno, Kenichi Mishima, Katsunori Iwasaki, Ryozo Oishi, Michihiro Fujiwara · 2011 · Pharmacology Biochemistry and Behavior
  30. Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and Psilocybin
    Harold A. Abramson, A. Rolo, B. Sklarofsky, J. Stache · 1960 · The Journal of Psychology
  31. Activation of adenosine1 (A1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats
    Gerard J. Marek · 2009 · Neuropharmacology
  32. Effect of 8-OH-DPAT on temporal discrimination following central 5-hydroxytryptamine depletion
    S. Body, T.-J. Chiang, Sirous Mobini, M.-Y. Ho, C. M. Bradshaw, E. Szabadi · 2002 · Pharmacology Biochemistry and Behavior
  33. Lisuride treatment of Restless Legs Syndrome: first studies with monotherapy in de novo patients and in combination with levodopa in advanced disease
    Heike Beneš, A. Deissler, A. Rodenbeck, A. Engfer, Ralf Kohnen · 2005 · Journal of Neural Transmission
  34. Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine]
    Jesse A. May, Najam A. Sharif, Hwang-Hsing Chen, John C. Liao, Curtis R. Kelly, Richard A. Glennon, Richard Young, Jun‐Xu Li, Kenner C. Rice, Charles Patrick France · 2008 · Pharmacology Biochemistry and Behavior
  35. 5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail
    Zoë Barclay, Louise Dickson, Derek N. Robertson, Melanie S. Johnson, Pamela J. Holland, Roberta Rosie, Liting Sun, Sue Fleetwood‐Walker, E.M. Lutz, Rory Mitchell · 2011 · Biochemical Journal
  36. Effects of Lysergic Acid Diethylamide (LSD) on the Time Sense of Normals
    William K. Boardman · 1957 · A M A Archives of Neurology & Psychiatry
  37. Lisuride in Cluster Headache
    Edgard Raffaelli, Orlando J. Martins, Americo dos Santos Poça Dagua Filho · 1983 · Headache The Journal of Head and Face Pain
  38. Mapping of CBV changes in 5-HT1A terminal fields by functional MRI in the mouse brain
    Thomas Mueggler, Florence Razoux, Holger D. Russig, Anna Buehler, Tamara B. Franklin, Christof Baltes, Isabelle M. Mansuy, Markus Rudin · 2010 · European Neuropsychopharmacology
  39. Effects of GABAB, 5-HT1A, and 5-HT2 receptor stimulation on activation and inhibition of the rat lateral amygdala following medial geniculate nucleus stimulation in vivo
    David M. Sokal, Alessandra Giarola, Charles H. Large · 2004 · Brain Research
  40. Strain‐dependent serotonin neuron feedback control: role of serotonin2Creceptors
    Eleonora Calcagno, Roberto William Invernizzi · 2010 · Journal of Neurochemistry
  41. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats
    Marshall B. Wallach, Bromfield Hine, Samuel Gershon · 1974 · European Journal of Pharmacology
  42. Note on the Spectroscopy of Subjective Light Patterns
    Max Knoll, Johann Kugler, Joseph Eichmeier, OSKAR HÖFER · 1962 · Journal of Analytical Psychology
  43. LSD and JB318: A Comparison of Two Hallucinogens
    Binyamin Z. Lebovits · 1960 · A M A Archives of General Psychiatry
  44. Electroencephalographic studies on the development of tolerance and cross tolerance to mescaline in the rat
    Brenda K. Colasanti, Naim Khazan · 1975 · Psychopharmacology
  45. Hallucinogenic drugs: influence of mental set and setting.
    Louis A. Faillace, Stephen Szára · 1968 · PubMed
  46. Effects of N,N-dimethyltryptamine on electrically evoked responses in the cat visual system and modification by neuroleptic agents
    R.H. Moore, K. Hatada, Edward F. Domino · 1976 · Neuropharmacology
  47. Mescal: A Study of a Divine Plant
    Havelock Ellis · 1902 · Scientific American
  48. Behavioral effects of xylamine-induced depletions of brain norepinephrine: Interaction with LSD
    Mark A. Geyer, Joanne Gordon, Lynne M. Adams · 1985 · Pharmacology Biochemistry and Behavior
  49. Studies on cross tolerance with LSD-25, UML-491 and JB-336
    Antonio Balestrieri · 1960 · Psychopharmacology
  50. Experimentally induced depersonalization.
    Von Mering O, K Morimoto, Hyde Rw, M Rinkel · 1955 · PubMed
  51. Electrophysiological studies of d-lysergic acid diethylamide in the visual system
    Warren E. Foote · 1982 · Neuroscience & Biobehavioral Reviews
  52. Nefazodone in the rat: mimicry and antagonism of [−]-DOM-induced stimulus control
    J.R. Eckler, R.A. Rabin, Jerrold C. Winter · 2003 · Pharmacology Biochemistry and Behavior
  53. Modification of the effects of LSD-25, d-amphetamine and tryptamine on electrically evoked responses in the visual system by methiothepin and octoclothepin.
    Moore Rh, Domino Ef · 1978 · PubMed
  54. Dream Scintillations
    Mardi J. Horowitz, John E. Adams, B. Rutkin · 1967 · Psychosomatic Medicine
  55. 36. MODEL PSYCHOSES INDUCED BY LSD–25 IN NORMALS I. Psychophysiological Investigations, with Special Reference to the Mechanism of the Paranoid Reaction
    Nicholas A. Bercel, Lee Edward Travis, Leonard B. Olinger, Eric Dreikurs · 1958 · Harvard University Press eBooks
  56. Untitled work
    2000 · 10.1002/1098-2396(20001215)38:4
  57. Untitled work
    Cornea-Hébert · 1999 · 10.1002/(sici)1096-9861(19990628)409:2
  58. Untitled work
    Wang · 1997 · 10.1002/(sici)1098-2396(199709)27:1